SUBSCRIBERS

Lonza buying capsule maker for US$5.5b

Published Thu, Dec 15, 2016 · 09:50 PM
Share this article.

Zurich

LONZA Group AG, which has a secondary listing in Singapore, has agreed to buy US capsule maker Capsugel SA from KKR & Co for US$5.5 billion, as the Swiss biotech and specialty chemicals company seeks to focus more on health care.

The price includes refinancing of existing Capsugel debt of about US$2 billion, Basel-based Lonza and Capsugel, which has headquarters in Morristown, New Jersey, said in a statement on Thursday.

It added that the deal will be financed by a combination of debt and equity raising of as much as 3.3 billion francs (S$4…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Companies & Markets

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here